Baker Brothers Advisors - CENTESSA PHARMACEUTICALS PLC ownership

CENTESSA PHARMACEUTICALS PLC's ticker is CNTA and the CUSIP is 152309100. A total of 50 filers reported holding CENTESSA PHARMACEUTICALS PLC in Q2 2021. The put-call ratio across all filers is - and the average weighting 2.1%.

Quarter-by-quarter ownership
Baker Brothers Advisors ownership history of CENTESSA PHARMACEUTICALS PLC
ValueSharesWeighting
Q2 2022$5,490,000
-45.7%
1,127,2730.0%0.03%
-46.6%
Q1 2022$10,112,000
-20.3%
1,127,2730.0%0.06%
-6.5%
Q4 2021$12,693,000
-32.6%
1,127,2730.0%0.06%
-25.3%
Q3 2021$18,825,000
+111.9%
1,127,273
+181.8%
0.08%
+112.8%
Q2 2021$8,884,000400,0000.04%
Other shareholders
CENTESSA PHARMACEUTICALS PLC shareholders Q2 2021
NameSharesValueWeighting ↓
OUP Management Co., LLC 2,937,615$19,006,36942.74%
Medicxi Ventures Management (Jersey) Ltd 19,963,157$129,161,62641.24%
Vida Ventures Advisors, LLC 3,931,818$25,438,86239.38%
TCG Crossover Management, LLC 2,040,816$13,204,0791.94%
Affinity Asset Advisors, LLC 1,018,091$6,587,0491.85%
BVF INC/IL 9,103,054$58,896,7591.59%
Sio Capital Management, LLC 756,891$4,897,0851.52%
ACUTA CAPITAL PARTNERS, LLC 323,349$2,092,0681.40%
EcoR1 Capital, LLC 5,618,779$36,353,5001.23%
GENERAL ATLANTIC, L.P. 9,681,818$62,641,3620.97%
View complete list of CENTESSA PHARMACEUTICALS PLC shareholders